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ReviewCanine leishmaniasis (CanL) caused by Leishmania
infantum is a vector-borne disease of great veterinary
and medical significance. Prevention of CanL requires a
combined approach including measures focused on
dogs and the environment where the vectors perpetu-
ate. Over past decades, considerable effort has been put
towards developing novel and cost-effective strategies
against CanL. Vaccination is considered among the most
promising tools for controlling CanL, and synthetic pyr-
ethroids are useful and cost-effective in reducing risk of
L. infantum infection in dogs. The effectiveness of the
use of vaccines plus repellents in preventing L. infantum
infection and subsequent disease development should
be assessed by means of large-scale, randomized con-
trolled field trials because this combined strategy may
become the next frontier in the control of CanL.
An emerging zoonotic threat
Canine leishmaniasis (CanL) caused by Leishmania infan-
tum is among the most important vector-borne parasitic
diseases of dogs, occurring on all continents, except Ocea-
nia [1]. In dogs, the infection may be asymptomatic (over
80% of cases in some areas) or may evolve to life-threaten-
ing overt disease, with a wide range of clinical signs (from
localized skin alterations to severe loss of weight and
generalized lymphadenomegaly). For its potential severity
in dogs and its zoonotic nature, the prevention of this
infection is not only desirable but also a must for both
dog and human health (Figure 1). Because the infection to
a receptive host occurs through the bite of sand flies of the
genus Phlebotomus (in the Old World) and genus Lutzo-
myia (in the Americas) [2], the management of this disease
is extremely complex [1,3]. In this regard, the prevention of
CanL should include measures targeting animals (at indi-
vidual and population level) and the environment. Howev-
er, the adoption and transportation of dogs from areas of
CanL endemicity has resulted in the introduction and
spread of disease to regions where infections were not
previously found [4–6], which may create new epidemio-
logical scenarios, further complicating the zoonotic poten-
tial. This often occurs in combination with emerging
immunosuppressive conditions in humans (e.g., HIV/
AIDS) that may increase the risk of zoonotic diseases such1471-4922/$ – see front matter
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pyrethroids; control.as visceral leishmaniasis (VL) [7]. Although the risk of
CanL transmission is reputed to be low in the absence of
sand flies, other ways of transmission, such as venereal
and transplacental transmission, should be seriously con-
sidered [8]. Here, we summarize the main difficulties in
setting control plans as well as current knowledge on the
prevention and control of CanL, with emphasis on current-
ly available tools and future research needs.
Canine and human leishmaniasis
Dogs are regarded as the principal reservoirs of L. infan-
tum, and for this reason they are the target of control
programs in some countries, such as in Brazil, where
approximately 3500 human cases of zoonotic VL are
reported each year [1]. This figure is significantly different
from the Mediterranean region, where approximately 875
human cases are reported annually [9]. However, although
CanL is thought to be highly prevalent in several countries,
mainly in South America and in the Mediterranean region
(Figure 1), a precise account of its actual distribution and
frequency is currently unavailable. Based on serological
surveys, it has been estimated in the past that over 2.5
million L. infantum-infected dogs are present in southern
Europe [10]; from these numbers, pervasive infection of
dogs with L. infantum does not necessarily imply a higher
incidence of the disease in humans. Importantly, stray
dogs that are not treated with proper preventatives (e.g.,
insecticide-impregnated collars) may potentially play a
role in maintaining CanL, in areas where the disease is
endemic. In some European countries, the existence of
municipal kennels, where dogs are kept throughout their
life, may represent a major barrier to the control of CanL
(Figure 1). Under these conditions, focal spots of CanL may
easily occur with infection of up to 35% of dogs exposed to
sand fly bites over a single season [11]. This picture high-
lights how pivotal it is to control CanL by different
approaches according to the epidemiology of the disease
in a given area and the difficulties inherent to local con-
ditions [1].
Difficulties in setting control plans
The control of CanL is a difficult task because of the
complex transmission cycle of L. infantum. Based on cur-
rent knowledge and considering the tools available, the
environmental control of immature sand flies is unfeasible
because the microhabitats of larvae and pupae are ex-
tremely variable, including, for example, tree roots, animal
burrows, decaying foliage, and tree holes [2]. Similarly,Trends in Parasitology, July 2013, Vol. 29, No. 7 339
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Figure 1. Mediterranean environments where canine leishmaniosis is endemic. (A) Rural hilly areas of southern Italy where shepherd and hunting dogs live in close contact
with humans. (B) Typical shelter where hundreds of stray dogs live throughout their life and are exposed to sand fly bites.
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control is useless and that the residual effect of house wall
spraying is very short [12], making the residual spraying of
houses impractical and ineffective, particularly in rural
areas [13].
A proper assessment of the infection status of dogs is
fundamental for a better determination of actions to be
taken, to start the treatment in the initial stages of the
disease, and to monitor the effectiveness of control mea-
sures. In areas where L. infantum is prevalent, most of the
dogs and people exposed to sand flies will come into contact
with the parasite, but remain asymptomatic [14,15]. Al-
though asymptomatic dogs may potentially be infectious
to sand flies [16,17], the role of asymptomatic humans in
the epidemiology of VL has yet to be ascertained [15]. It is
worth noting that the definitive diagnosis of L. infantum
infection in asymptomatic dogs and people is often trou-
blesome due to the inherent limitations of serological and
parasitological methods [15,18]. For example, serology
may not be a good indicator of infection due to the variable
time in seroconversion. Additionally, the costs attached to
the systematic serological testing of dogs may be difficult
to handle by local public health authorities, especially in
large countries such as Brazil where the number of dogs
living in areas with a high rate of infection might be huge
[1,6,14,19]. Conversely, microscopic examination of
stained smears (e.g., lymph node and bone marrow) is a
simple method, but has a low sensitivity, particularly in
asymptomatic dogs [6], whereas molecular tools, although
the most sensitive and specific, often have prohibitive
costs [6,20]. Available data clearly show that there is no
gold standard to detect Leishmania infections in asymp-
tomatic dogs [6], indicating that improved diagnostic tests
are needed.
Environmental and on-host vector control
In spite of the major concerns related to the complex
ecology of vectors, control measures aimed at reducing
vector populations in the environment have also been
employed. The application of insecticides may eventually
have a transitory effect but is typically unsustainable in
the long term for several technical and economic reasons.340For example, a variety of sand fly species may be poten-
tially involved in the transmission of L. infantum [2],
and the ecology and behavior of each species may vary
widely. Similarly, the size of the area to be treated in
countries such as Brazil where leishmaniasis is endemic
may be vast and make environmental control economi-
cally unaffordable.
The application of insecticides on the walls and roofs of
human habitations (indoor residual spraying; IRS) and in
animal shelters (e.g., chicken pens and corrals) was shown
to be effective in reducing the population of sand flies
[13,21]. Environmental and human health hazard con-
cerns around the employment of organochlorides and other
chemical groups (e.g., organophosphates and carbamates)
have progressively led to their substitution by synthetic
pyrethroids (e.g., a-cypermethrin, cypermethrin, deltame-
thrin, and l-cyhalothrin), which are currently used by
public health authorities in several countries.
Another major constraint in employing insecticides in
the environment for sand fly control relies on the fact that
their natural resting and breeding sites are difficult to find
[13]. However, IRS may be useful in particular situations,
such as when a high density of sand flies is found near or in
human habitations. Similarly, chicken coops, pigsties, cor-
rals, and dog shelters may represent a ‘natural lure’ for the
vectors [22,23] and should be targeted by control activities.
In any case, information on sand fly population dynamics is
fundamental to optimize timing and modalities of insecti-
cide applications. Microhabitats favorable to their devel-
opment, for example, in crevices and cracks on the walls
and humid soil in shaded areas, should also be removed
[13]. Furthermore, the destruction of these microhabitats
has been considered as one of the few examples of effective
noninsecticidal control of sand flies [13], but such a mea-
sure is difficult to apply; there is no convincing scientific
evidence showing that cleaning microhabitats may have an
impact on the incidence of VL in humans and dogs.
The use of repellents such as synthetic pyrethroids on
dogs has become the most effective tool for prevention of
L. infantum infection in these animals. Their mode of
action, a toxic and irritating effect on sand flies, causes
insect disorientation and sudden abandonment of the host
Table 1. Efficacy of pyrethroids to prevent CanL under field conditions
Pharmaceutical compound Formulation Study site Study duration Treated dogs Untreated animals
(incidence)
Efficacy (%) Refs
Imidacloprid 10% and
permethrin 50%
Spot-on Italy 12 months 209a; 204b 218 (9.8%) 89%a; 90.3%b [37]
Permethrin 65% Spot-on Brazil 4 months 230 160 (7.4%) 50% [71]
Permethrin 65% Spot-on Italy 2 seasons 120 188 (15%) 84% [72]
Deltamethrin 4% Collars Italy 2 seasons 119 188 (15%) 84% [72]
Imidacloprid 10% and
permethrin 50%
Spot-on Italy 24 months 71 56 (47.6%) 100% [3]
Deltamethrin 4% Collars Italy 2 seasons 354 371 (25.8%) 50–86% [34]
Deltamethrin 4% Collars Italy 2 seasons 60 60 (41.2%) 51% [73]
Deltamethrin 4% Collars Tunisia 2 seasons 42 38 (15.8%) 100% [74]
Deltamethrin 4% Collars Iran 6 months 354 466 (6.6%) 54%c [71]
Deltamethrin 4% Collars Brazil 12 months 136 97 (17.6%) 50% [33]
Imidacloprid 10% and
flumethrin 4.5%
Collars Italy 24 months 63 61 (35.3%) 100% [11]
aDogs treated once a month.
bDogs treated twice a month.
cThis is an estimation of reduction in dog seroconversion during a transmission season.
Review Trends in Parasitology July 2013, Vol. 29, No. 7followed by death soon after the landing of an insect on the
coat of a treated animal. Hence, bloodfeeding usually does
not occur and infection is usually prevented (Table 1). The
effect of synthetic pyrethroids in spot-on formulations or
collars (Figure 2) may last from 1 to approximately 8
months, respectively [3,11,24].
When a spot-on formulation is applied, it usually takes
24 h for the insecticide to spread throughout the stratum
corneum. It is recommended to apply the first treatment 1
month before the sand fly season occurs in order to achieve
the highest level of protection [3]. On the contrary, powders
and sprays have an immediate effect but a short residual
activity. Moreover, the use of a slow-release collar matrix
system with a combination of 10% imidacloprid and 4.5%
flumethrin (Seresto1, Bayer Animal Health) has resulted in
an increased period of efficacy against ticks and fleas [25,26].
The efficacy of several repellents against sand flies has
been evaluated under laboratory and field conditions withTRENDS in Parasitology 
Figure 2. Dog with a pyrethroid-impregnated collar. Synthetic pyrethroid-
impregnated collars were shown to be effective in protecting dogs form
Leishmania infantum infection under field conditions.encouraging results. For example, the insecticidal effect of
deltamethrin and permethrin, alone or in combination
with other insecticides (e.g., imidacloprid), was experimen-
tally tested against different sand fly vectors by evaluating
the number of unfed female sand flies collected soon after
contact with a treated animal and their mortality within
24 h after exposure to treated dogs [27–32]. The results of
laboratory studies were generally positive, with an anti-
feeding effect ranging from 84% to 96% of sand flies and an
insecticidal activity of near 100% in the few fed females.
These results fostered field investigations in the Old and
the New Worlds with the ultimate goal of finding an
effective product to protect dogs. The use of pyrethroids
with repellent properties in impregnated collars [33] and
spot-on formulations [3] was demonstrated to be a suitable
approach to reduce the risk of L. infantum infection in dogs.
Specifically, collars containing 4% deltamethrin (Scali-
bor1, Intervet) [34,35] or 10% imidacloprid and 4.5% flu-
methrin [11], and a spot-on formulation containing 10%
imidacloprid and 50% permethrin (Advantix1, Bayer) [3]
have been used for reducing the biting rate of sand fly
vectors, exhibiting protection rates ranging from 50% to
100% over two consecutive transmission seasons (Table 1).
Based on current knowledge, topical insecticides used on
dogs represent a promising tool for reducing the transmis-
sion of infection to dogs [11,34–37]. Large-scale studies in
Brazil would be needed to assess whether the massive use
of collars in dogs living in a given community would impact
on the incidence of the disease in humans.
Vaccination
Over the past decades, considerable effort has been made
towards selecting potential Leishmania antigens as vaccine
candidates as well as the best adjuvant for such vaccines
[38]. Because initial unsuccessful attempts using inacti-
vated vaccines prepared with disrupted promastigotes of
Leishmania braziliensis or alum-precipitated, autoclaved
Leishmania major with Bacillus Calmette–Guerin as an
adjuvant [39–41], second-generation vaccines composed of
whole cultured parasites or their excretory–secretory (ES)341
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available in recent years. For example, a vaccine prepared
with a glycoprotein known as the fucose mannose ligand of
Leishmania donovani (Leishmune1, Fort Dodge Animal
Health) has been licensed for use in Brazil [42–44], and it
showed a field efficacy of 76% and protection of 92% [42]. The
use of this vaccine in the immunotherapy of CanL was also
suggested [45], and, in the field, it was correlated with a
decreased incidence of infection in dogs and humans [46].
Nonetheless, the Brazilian Ministry of Health has not
adopted it as a control measure thus far, even if veterinary
practitioners have recommended this vaccine at the individ-
ual level. Another vaccine using ES antigen purified from
culture supernatant of L. infantum promastigotes and Quil-
laja saponaria (QA21) as an adjuvant (CaniLeish1, Virbac
Animal Health) has been licensed recently in Europe, and a
prototype of this vaccine (with a different adjuvant) dis-
played 92% efficacy in protecting animals against the ap-
pearance of clinical signs, under field conditions, in France
[47]. However, further large-scale field studies are necessary
to assess whether this vaccine will contribute to the control of
CanL in Europe. Analogously, the efficacy of other vaccines
such as a vaccine using a recombinant A2-antigen of Leish-
mania amastigotes with saponin as adjuvant (Leish-Tec1,
Hertape Calier) needs to be further evaluated under field
conditions [48].
Several other vaccine candidates have been tested with
less promising results. These include multisubunit recom-
binant Leishmania vaccines, based on expression of poly-
protein (Leish-111) [49] or Leishmania analog of the
receptors of activated C kinase (LACK) antigen [50]. Fur-
thermore, fourth-generation vaccines were prepared with
L. infantum cysteine proteinases (types I and II) and pro-
tected ten dogs (90% protection) against experimental
L. infantum infection, after 12 months of challenge [51],
whereas a multiantigenic plasmid DNA encoding four pro-
teins did not [52]. The vaccines prepared for L. infantum and
the efficacy in experimental and field trials are summarized
in Table 2. Although vaccines represent the next frontier in
the control of CanL, several concerns linked with their use
(e.g., prohibitive costs) still need to be addressed.
Treatment of infected dogs
The treatment of dogs with CanL is not only aimed at
increasing their life expectancy and improving quality of
life but also to diminish the parasite load, thereby reducing
their infectiousness to sand flies. Indeed, the treatment of
CanL has evolved considerably in the past decades, and
available protocols may promote clinical cure of infectedTable 2. Efficacy and protection of vaccines currently licensed to 
Vaccine Antigenic composition 
Leishmune1 L. donovani FML antigen and QS21 and deacylated sa
Canileish1a Excreted–secreted proteins of L. infantum (LiESP), plu
(QA-21) of the Q. saponaria saponin
Leish-Tec1a A2 recombinant protein plus saponin 
aPhase III trials have not been published in the international scientific literature yet.
bOliva, G. et al. (2012) Evidence for protection against active infection and disease prog
consecutive Leishmania infantum transmission seasons. The World Small Animal Veter
Associations (FECAVA)/British Small Animal Veterinary Association (BSAVA) Congres
cUnavailable.
Abbreviation: FML, fucose mannose ligand.
342dogs, reduce parasite load considerably, and decrease the
risk of L. infantum transmission [1,53]. For example, a
reduction in the Phlebotomus perniciosus infection rate
after treatment with meglumine antimoniate, alone or
associated with allopurinol, was recorded in L. infan-
tum-infected dogs [54,55]. Indeed, the use of allopurinol
in association with meglumine antimoniate treatment
could contribute to keeping dogs noninfectious, especially
during the disease transmission season (from late May to
early October in southern Europe). The reduced capacity of
infectiousness to sand flies might be the effect of clinical
improvement and reduction of parasite load on the skin, as
demonstrated in Brazil where an innovative liposomal
formulation of meglumine antimoniate was used in combi-
nation with allopurinol to treat dogs suffering from CanL
[56]. Altogether, these studies clearly indicate the benefits
of treating infected dogs in areas where L. infantum infec-
tion is endemic.
Dog culling: an unethical and useless practice
The elimination of dogs to control human leishmaniasis was
first conducted in Palestine, China, and the Central Asian
republics of the then Soviet Union [57]. Specifically, in China
these initiatives were supported by the centralized state as
part of the socialist revolutionary doctrine with a tremen-
dous effort to simultaneously combine a mass treatment of
human patients, vector control in the environment with
dichlorodiphenyltrichloroethane (DDT), and elimination
of dogs [57]. Importantly, the disease in humans was caused
by both L. donovani (predominantly in the eastern plains)
and L. infantum (concentrated in the mountain areas of
Beijing and Gansu), responsible for anthroponotic and zoo-
notic VL, respectively [58]. Expectedly, human treatment
and vector control resulted in the interruption of transmis-
sion in areas of anthroponotic transmission, and by the
1970s leishmaniasis was a relatively rare disease in China
[57]. Even in areas of zoonotic transmission, the successful
control of the disease was attributed to the mass treatment
of human patients and to the use of insecticides for vector
control, making the actual effect of dog elimination difficult
to assess [57]. However, numerous dogs were eliminated,
with no definite criteria, as any dog found in areas where
infection was endemic was indiscriminately killed. In 2008,
an outbreak of human VL was detected in the western part
of China with the incidence rate of disease increased more
than 20-fold compared with the mean annual incidence rate
[59]. This suggests that the disease has never been eradi-
cated and that the effect of dog culling, if any at all, was
momentary.prevent canine leishmaniasis
Efficacy/protection Refs
ponins of Quillaja saponaria 76%/92% [75,76]
s a highly purified fraction 68.4%/92.7% (-)b
(-)c [48]
ression in naı¨ve dogs vaccinated with LiESP/QA-21 (CaniLeish1) exposed to two
inary Association (WSAVA)/Federation of European Companion Animal Veterinary
s, Birmingham, UK.
Box 1. Control of CanL: the way forward
 Vaccination
 Vaccine against infection (not only disease).
 Vaccines based on concealed antigens of sand flies to prevent
infection.
 Diagnosis and treatment
 Rapid, high sensitivity, point-of-care tests for CanL.
 Drug resistance of Leishmania infantum and impact on public
health.
 Transmission of the infection
 Role of animals other than dogs as reservoirs or amplifying
hosts of L. infantum.
 Alternative ways of L. infantum transmission in the absence of
sand fly vectors.
 Hazard for introduction of other Leishmania species and/or
vectors.
 Prevention and control
 Usefulness of repellents from natural extracts to prevention of
sand fly bites.
 Impact of vector control on the risk of L. infantum transmission
to humans.
Review Trends in Parasitology July 2013, Vol. 29, No. 7In Brazil, CanL control has long been based on the
culling of seropositive dogs [1]. However, there is no scien-
tific evidence that this strategy could reduce the incidence
of zoonotic VL [12]. Moreover, Brazil remains among the
six countries responsible for 90% of the global cases of
zoonotic VL reported worldwide [9]. Not least, the dog
culling strategy has not been accepted in Brazil for ethical
reasons [57], but public health authorities still insist on
recommending this measure. The reasons for the failure of
the dog culling strategy used in Brazil have been exten-
sively discussed in recent years [1,12,60] and these include:
(i) other animals (e.g., marsupials, rodents, and humans
themselves) may act as reservoirs of L. infantum [60]; (ii)
dog population screenings for L. infantum may be very
inaccurate when based on serological tests [e.g., enzyme-
linked immunosorbent assay (ELISA) and indirect immu-
nofluorescence antibody test (IFAT)] [61,62]; and (iii) the
rapid replacement of culled dogs with young animals
increases the proportion of susceptible animals in the
population [63]. The ineffectiveness of such a strategy is
indicated by the rising trend in the number of human cases
of zoonotic VL observed between the years 1990 and 2010
[1], in spite of the incalculable number of dogs killed during
the past decades.
Concluding remarks and future perspectives
From an epidemiological point of view, CanL is a multifac-
eted disease and for this reason its control is not easy to
achieve. In fact, the control of such a complex disease
requires a well-rounded approach, based on current knowl-
edge of the biology of the parasite and its vector, while at
the same time also considering interaction with the host at
individual and population levels. At present, different
strategies are available for the prevention and control of
CanL, including vaccination, use of repellents, and the
treatment of infected dogs (Figure 3). Importantly, the
effectiveness of the combined use of repellents plus vacci-
nation in the prevention of CanL should be assessed in
large-scale randomized controlled field trials.Retest to conﬁrm. M
signs and laborator
and retest every
Consider the diagnosis of
other disease
Clinical and serological mon
(every 6–12 months)
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Negave
(serology, cytology, and PCR)
Treatment according to current
guidelines
Figure 3. Suggested management of canine leishmanA high percentage of asymptomatic infections may occur
in dogs [14] and humans [15], and evidence indicates that
both may potentially serve as a source of infection to sand
fly vectors [15–17,64]. Relevantly, the definitive diagnosis
of L. infantum infection in asymptomatic dogs is trouble-
some due to the inherent limitations of serological and
parasitological methods [18].
In spite of the advancements in terms of research and
development in this field, several issues require more
attention from researchers in the near future (Box 1). Of
particular interest are studies on host immune response to
leishmanial and sand fly antigens. For example, immuno-
genic as well as immunosuppressive molecules released by
sand flies while taking a blood meal greatly interfere with
the individual hemostasis and host immune response [65].
The IgG response to sand fly saliva measured in a popula-
tion of dogs in southern Italy was negatively correlated
with risk of L. infantum transmission [66]. Possibly, this
approach could help to evaluate the effectiveness of vectorNo clinical signs and/or laboratory
abnormalies compable with CanL
Seroposive
onitor for clinical
y abnormalies
 3–6 months
Monitor every 6–12 months to
evaluate seroconversion and/or the 
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infection for humans and individual dogs living nearby.
In addition, further studies on the interactions between
immunomodulatory molecules present in sand fly saliva
and the host immune response would contribute to the
development of vaccines using sand fly concealed antigen.
Currently, the use of repellents in different formula-
tions may induce a high degree of protection in dogs at
individual and population levels. Governmental authori-
ties should settle affordable surveillance systems to opti-
mize economic resources and to achieve the best outputs
possible. Nonetheless, the costs of control campaigns at the
population level are often not affordable for the local
governmental authorities in developing as well as in de-
veloped countries. Therefore, in a time of global economic
crisis, stray and sheltered dogs maintained in municipal
kennels may represent a risk factor for zoonotic VL trans-
mission in areas with a high rate of infection and high
vector densities. Indeed, the contribution of the community
wide use of dog collars on the incidence of VL in humans
should be confirmed in large-scale surveys. In Iran, the use
of deltamethrin-impregnated collars in dogs reduced the
risk of infection in dogs by 54% and in children by 43%, as
assessed by serology; however, no effect was observed
when humans were assessed by skin test [69]. By contrast,
in Brazil where dog culling is a common practice, cases of
human VL are increasing and expanding in terms of
geographical distribution in some areas [70], indicating
that the use of such unethical and above-all inefficacious
strategies should be discontinued.
Finally, synergism between medical physicians, veteri-
nary practitioners, researchers, public health authorities,
and politicians is central to find a one-base platform for
planning sustainable control strategies against CanL, and
also from a one-health perspective.
Acknowledgments
The authors thank Alessio Giannelli (University of Bari, Italy) for his
assistance during manuscript preparation.
References
1 Dantas-Torres, F. et al. (2012) Canine leishmaniosis in the Old and
New Worlds: unveiled similarities and differences. Trends Parasitol.
28, 531–538
2 Maroli, M. et al. (2013) Phlebotomine sand flies and the spreading of
leishmaniases and other diseases of public health concern. Med. Vet.
Entomol. 27, 123–147
3 Otranto, D. et al. (2010) Prevention of endemic canine vector-borne
diseases using imidacloprid 10% and permethrin 50% in young dogs: a
longitudinal field study. Vet. Parasitol. 172, 323–332
4 Maroli, M. et al. (2008) The northward spread of leishmaniasis in Italy:
evidence from retrospective and ongoing studies on the canine
reservoir and phlebotomine vectors. Trop. Med. Int. Health 13, 256–264
5 Petersen, C.A. and Barr, S.C. (2009) Canine leishmaniasis in North
America: emerging or newly recognized? Vet. Clin. North Am. Small
Anim. Pract. 39, 1065–1074
6 Otranto, D. et al. (2009) Toward diagnosing Leishmania infantum
infection in asymptomatic dogs in an area where leishmaniasis is
endemic. Clin. Vaccine Immunol. 16, 337–343
7 Fernande´z-Guerrero, M.L. et al. (2004) Visceral leishmaniasis in
immunocompromised patients with and without AIDS: a comparison
of clinical features and prognosis. Acta Trop. 90, 11–16
8 Naucke, T.J. and Lorentz, S. (2012) First report of venereal and vertical
transmission of canine leishmaniosis from naturally infected dogs in
Germany. Parasit. Vectors 5, 673449 Alvar, J. et al. (2012) Leishmaniasis worldwide and global estimates of
its incidence. PLoS ONE 7, e35671
10 Moreno, J. and Alvar, J. (2002) Canine leishmaniasis: epidemiological
risk and the experimental model. Trends Parasitol. 18, 399–405
11 Otranto, D. et al. (2013) Prevention of canine leishmaniosis in a hyper-
endemic area using a combination of 10% imidacloprid/4.5% flumethrin.
PLoS ONE 8, e56374
12 Romero, G.A. and Boelaert, M. (2010) Control of visceral leishmaniasis
in Latin America – a systematic review. PLoS Negl. Trop. Dis. 4, e584
13 Alexander, B. and Maroli, M. (2003) Control of phlebotomine sandflies.
Med. Vet. Entomol. 17, 1–18
14 Dantas-Torres, F. et al. (2006) Seroepidemiological survey on canine
leishmaniasis among dogs from an urban area of Brazil. Vet. Parasitol.
310, 54–60
15 Costa, C.H. et al. (2002) Asymptomatic human carriers of Leishmania
chagasi. Am. J. Trop. Med. Hyg. 66, 334–337
16 Molina, R. et al. (1994) Infectivity of dogs naturally infected with
Leishmania infantum to colonized Phlebotomus perniciosus. Trans.
R. Soc. Trop. Med. Hyg. 88, 491–493
17 Michalsky, E.M. et al. (2007) Infectivity of seropositive dogs, showing
different clinical forms of leishmaniasis, to Lutzomyia longipalpis
phlebotomine sand flies. Vet. Parasitol. 147, 67–76
18 Miro´, G. et al. (2008) Canine leishmaniosis – new concepts and insights
on an expanding zoonosis: part two. Trends Parasitol. 8, 371–377
19 Baneth, G. (2006) Leishmaniases. In Infectious Diseases of the Dog and
Cat (3rd edn) (Greene, C.E., ed.), pp. 685–698, Saunders/Elsevier
20 Paiva Cavalcanti, M. et al. (2009) The development of a real-time PCR
assay for the quantification of Leishmania infantum DNA in canine
blood. Vet. J. 182, 356–358
21 Maroli, M. et al. (2010) Guidelines for prevention of leishmaniasis in
dogs. J. Am. Vet. Med. Assoc. 236, 1200–1206
22 Tarallo, V.D. et al. (2010) Phlebotomine sand fly population dynamics
in a leishmaniasis endemic peri-urban area in southern Italy. Acta
Trop. 116, 227–234
23 Costa, P.L. et al. (2013) Ecology of Lutzomyia longipalpis in an area of
visceral leishmaniasis transmission in north-eastern Brazil. Acta Trop.
26, 99–102
24 Killick-Kendrick, R. (1999) The biology and control of phlebotomine
sand flies. Clin. Dermatol. 17, 279–289
25 Stanneck, D. et al. (2012) The synergistic action of imidacloprid and
flumethrin and their release kinetics from collars applied for
ectoparasite control in dogs and cats. Parasit. Vectors 5, 73
26 Stanneck, D. et al. (2012) Evaluation of the long-term efficacy and
safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar
(Seresto1) in dogs and cats naturally infested with fleas and/or ticks in
multicentre clinical field studies in Europe. Parasit. Vectors 5, 66
27 Halbig, P. et al. (2000) Further evidence that deltamethrin-
impregnated collars protect domestic dogs from sandfly bites. Med.
Vet. Entomol. 14, 223–226
28 David, J.R. et al. (2001) Deltamethrin-impregnated dog collars have a
potent anti-feeding and insecticidal effect on Lutzomyia longipalpis
and Lutzomyia migonei. Mem. Inst. Oswaldo Cruz 96, 839–847
29 Reithinger, R. et al. (2001) Topical insecticide treatments to protect
dogs from sand fly vectors of leishmaniasis. Emerg. Infect. Dis. 7,
872–876
30 Mencke, N. et al. (2003) Repellent efficacy of a combination containing
imidacloprid and permethrin against sand flies (Phlebotomus papatasi)
on dogs. Parasitol. Res. 90, 108–111
31 Molina, R. et al. (2006) Evaluation of a spray of permethrin and
pyriproxyfen for the protection of dogs against Phlebotomus
perniciosus. Vet. Rec. 159, 206–209
32 Miro`, G. et al. (2007) Evaluation of the efficacy of a topically
administered combination of imidacloprid and permethrin against
Phlebotomus perniciosus in dog. Vet. Parasitol. 143, 375–379
33 Reithinger, R. et al. (2004) Are insecticide-impregnated dog collars a
feasible alternative to dog culling as a strategy for controlling canine
visceral leishmaniasis in Brazil? Int. J. Parasitol. 34, 55–62
34 Maroli, M. et al. (2001) Evidence for an impact on the incidence of
canine leishmaniasis by the use of deltamethrin-impregnated dog
collars in southern Italy. Med. Vet. Entomol. 15, 358–363
35 Killick-Kendrick, R. et al. (1997) Protection of dogs from the bites of
phlebotomine sandflies by deltamethrin collars for the control of canine
leishmaniasis. Med. Vet. Entomol. 11, 105–111
Review Trends in Parasitology July 2013, Vol. 29, No. 736 Gavgani, A.S. et al. (2002) Domestic dog ownership in Iran is a risk
factor for human infection with Leishmania infantum. Am. J. Trop.
Med. Hyg. 67, 511–515
37 Otranto, D. et al. (2007) Efficacy of a combination of 10% imidacloprid/
50% permethrin for the prevention of leishmaniasis in kennelled dogs
in an endemic area. Vet. Parasitol. 144, 270–278
38 Palatnik-de-Sousa, C.B. (2008) Vaccines for leishmaniasis in the fore
coming 25 years. Vaccine 26, 1709–1724
39 Mayrink, W. et al. (1996) Phase I and II open clinical trials of a vaccine
against Leishmania chagasi infection in dogs. Mem. Inst. Oswaldo
Cruz 91, 695–697
40 Mohebali, M. et al. (2004) Double-blind randomized efficacy field trial of
alum precipitated autoclaved Leishmania major vaccine mixed with
BCG against canine visceral leishmaniasis in Meshkin-Shahr district,
I.R. Iran. Vaccine 22, 4097–4100
41 Giunchetti, R.C. et al. (2007) A killed Leishmania vaccine with sand fly
saliva extract and saponin adjuvant displays immunogenicity in dogs.
Vaccine 26, 623–638
42 Borja-Cabrera, G.P. et al. (2002) Long lasting protection against canine
kala-azar using FML-QuilA saponin vaccine in an endemic area of
Brazil (Sa˜o Gonc¸alo do Amaranto, RN). Vaccine 20, 3277–3284
43 Nogueira, F.S. et al. (2005) Leishmune 1 vaccine blocks the transmission
of canine visceral leishmaniasis. Absence of Leishmania parasite in
blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine 23,
4805–4810
44 Silva, V.O. et al. (2001) A phase III trial of efficacy of the FML vaccine
against canine kala-azar in an endemic area of Brazil (Sa˜o Gonc¸alo do
Amaranto, RN). Vaccine 19, 1082–1092
45 Borja-Cabrera, G.P. et al. (2010) Immunotherapy with the saponin
enriched-Leishmune vaccine versus immunochemotherapy in dogs
with natural canine visceral leishmaniasis. Vaccine 28, 597–603
46 Palatnik-de-Sousa, C.B. et al. (2009) Decrease of the incidence of
human and canine visceral leishmaniasis after dog vaccination with
Leishmune in Brazilian endemic areas. Vaccine 27, 3505–3512
47 Lemesre, J.L. et al. (2007) Long-lasting protection against canine
visceral leishmaniasis using the LiESAp-MDP vaccine in endemic
areas of France: double-blind randomized efficacy field trial. Vaccine
25, 4223–4234
48 Fernandes, A.P. et al. (2008) Protective immunity against challenge
with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with
recombinant A2 protein. Vaccine 26, 5888–5895
49 Gradoni, L. et al. (2005) Failure of a multi-subunit recombinant
Leishmania vaccine (MML) to protect dogs from Leishmania
infantum infection and to prevent disease progression in infected
animals. Vaccine 23, 5245–5251
50 Ramiro, M.J. et al. (2003) Protection in dogs against visceral
leishmaniasis caused by Leishmania infantum is achieved by
immunization with a heterologous prime-boost regime using DNA
and vaccinia recombinant vectors expressing LACK. Vaccine 21,
2474–2484
51 Rafati, S. et al. (2005) Protective vaccination against experimental
canine visceral leishmaniasis using a combination of DNA and protein
immunization with cysteine proteinase type I and II of L. infantum.
Vaccine 23, 3716–3725
52 Rodrı´guez-Corte´s, A. et al. (2007) Vaccination with plasmid DNA
encoding KMPII, TRYP, LACK and GP63 does not protect dogs
against Leishmania infantum experimental challenge. Vaccine 25,
7962–7971
53 Solano-Gallego, L. et al. (2011) The LeishVet Group. LeishVet
guidelines for the practical management of canine leishmaniosis.
Parasit. Vectors 4, 86
54 Gradoni, L. et al. (1987) Leishmania infantum infection rates in
Phlebotomus perniciosus fed on naturally infected dogs under
antimonial treatment. Med. Vet. Entomol. 1, 339–342
55 Miro´, G. et al. (2011) Infectivity to Phlebotomus perniciosus of dogs
naturally parasitized with Leishmania infantum after different
treatments. Parasit. Vectors 4, 5256 Silva, S.M. et al. (2012) Efficacy of combined therapy with liposome-
encapsulated meglumine antimoniate and allopurinol in treatment of
canine visceral leishmaniasis. Antimicrob. Agents Chemother. 56,
2858–2867
57 Costa, C.H. (2011) How effective is dog culling in controlling zoonotic
visceral leishmaniasis? A critical evaluation of the science, politics and
ethics behind this public health policy. Rev. Soc. Bras. Med. Trop. 44,
232–242
58 Lu, H.G. et al. (1994) Separation of Chinese Leishmania isolates into
five genotypes by kinetoplast and chromosomal DNA heterogeneity.
Am. J. Trop. Med. Hyg. 50, 763–770
59 Wang, J.Y. et al. (2010) An outbreak of the desert sub-type of zoonotic
visceral leishmaniasis in Jiashi, Xinjiang Uygur Autonomous Region,
People’s Republic of China. Parasitol. Int. 59, 331–337
60 Quinnell, R.J. and Courtenay, O. (2009) Transmission, reservoir
hosts and control of zoonotic visceral leishmaniasis. Parasitology
136, 1915–1934
61 Madeira, M.F. et al. (2006) Post mortem parasitological evaluation of
dogs seroreactive for Leishmania from Rio de Janeiro, Brazil. Vet.
Parasitol. 138, 366–370
62 Silva, D.A. et al. (2011) Laboratory tests performed on Leishmania
seroreactive dogs euthanized by the leishmaniasis control program.
Vet. Parasitol. 179, 257–261
63 Nunes, C.M. et al. (2008) Dog culling and replacement in an
area endemic for visceral leishmaniasis in Brazil. Vet. Parasitol.
153, 19–23
64 Costa, C.H.N. et al. (2013) Infectivity of symptomatic and
asymptomatic, non-HIV and HIV/Leishmania infantum infected,
patients to Lutzomyia longipalpis. In Abstract Book of the Fifth
World Congress on Leishmaniasis. 244–245
65 Oliveira, F. et al. (2009) Sand flies, Leishmania, and transcriptome-
borne solutions. Parasitol. Int. 58, 1–5
66 Vlkova, M. et al. (2011) Canine antibody response to Phlebotomus
perniciosus bites negatively correlates with the risk of Leishmania
infantum transmission. PLoS Negl. Trop. Dis. 5, e1344
67 Gomes, R.B. et al. (2007) Antibodies against Lutzomyia longipalpis
saliva in the fox Cerdocyon thous and the sylvatic cycle of Leishmania
chagasi. Trans. R. Soc. Trop. Med. Hyg. 101, 127–133
68 Hostomska, J. et al. (2008) Kinetics of canine antibody response to
saliva of the sand fly Lutzomyia longipalpis. Vector Borne Zoonotic Dis.
8, 443–450
69 Gavgani, A.S. et al. (2002) Effect of insecticide-impregnated dog collars
on incidence of zoonotic visceral leishmaniasis in Iranian children: a
matched-cluster randomised trial. Lancet 360, 374–379
70 Dantas-Torres, F. and Branda˜o-Filho, S.P. (2006) Geographical
expansion of visceral leishmaniasis in the State of Pernambuco.
Rev. Soc. Bras. Med. Trop. 39, 352–356
71 Giffoni, J.H. et al. (2002) Evaluation of 65% permethrin spot-on for
prevention of canine visceral leishmaniasis: effect on disease
prevalence and the vectors (Diptera: Psychodidae) in a
hyperendemic area. Vet. Ther. 3, 485–492
72 Ferroglio, E. et al. (2008) Evaluation of 65% permethrin spot-on and
deltamethrin-impregnated collars for canine Leishmania infantum
infection prevention. Zoonoses Public Health 55, 145–148
73 Foglia Manzillo, V. et al. (2006) Deltamethrin-impregnated collars for
the control of canine leishmaniasis: evaluation of the protective effect
and influence on the clinical outcome of Leishmania infection in
kennelled stray dogs. Vet. Parasitol. 142, 142–145
74 Aoun, K. et al. (2008) [Efficacy of deltamethrine-impregnated collars
Scalibor in the prevention of canine leishmaniasis in the area of Tunis].
Arch. Inst. Pasteur Tunis 85, 63–68 (in French)
75 Borja-Cabrera, G.P. et al. (2008) Immunogenicity assay of the
Leishmune vaccine against canine visceral leishmaniasis in Brazil.
Vaccine 26, 4991–4997
76 Palatnik-de-Sousa, C.B. et al. (2008) FML vaccine against canine
visceral leishmaniasis: from second-generation to synthetic vaccine.
Exp. Rev. Vaccines 7, 833–851345
